Recombinant Human Active p70 S6 Kinase Protein, CF

Catalog # Availability Size / Price Qty
896-KS-010
Recombinant Human Active p70 S6 Kinase Protein SDS-PAGE
1 Image
Product Details
Citations (4)
FAQs
Reviews

Recombinant Human Active p70 S6 Kinase Protein, CF Summary

Product Specifications

Purity
>85%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Activity
The activity of p70S6K was determined to be 73 nmol/min/mg using a synthetic peptide substrate.
Source
Spodoptera frugiperda, Sf 9 (baculovirus)-derived human p70 S6 Kinase protein
Accession #
N-terminal Sequence
Analysis
Using an N‑terminal His tag
SDS-PAGE
76 kDa

Product Datasheets

You must select a language.

x

896-KS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

896-KS

Formulation Supplied in 50 mM sodium phosphate (pH 7.0), 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.25 mM DTT, and 25% glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: This product is stable at ≤ -70°C for up to one year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Assay Procedure

Materials
  • Active Kinase - Active p70S6K (0.1 μg/μL) diluted with Kinase Dilution Buffer I and assayed as outlined in Sample Activity Plot. Note: These are suggested working dilutions.Optimal dilutions should be determined by each laboratory for each application.
  • Kinase Assay Buffer I - 25 mM MOPS, 12.5 mM beta -glycerol-phosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA. Add 0.25 mM DTT to the Kinase Assay Buffer prior to use.
  • Kinase Dilution Buffer - Kinase Assay Buffer I diluted at a 1:4 ratio (5X dilution) with distilled or deionized water.
  • 10 mM ATP Stock Solution - Prepare the ATP Stock Solution by dissolving 55 mg of ATP in 10 mL of Kinase Assay Buffer I. Store 200 μM aliquots at ≤-20 °C.
  • [33P]-ATP Assay Cocktail - Prepare 250 mM [33P]-ATP Assay Cocktail in a designated radioactive work area by combining 150 μL of 10 mM ATP Stock Solution, 100 μL of [33P]-ATP (1 mCi/100 mL), and 5.75 mL of Kinase Assay Buffer I. Store 1 mL aliquots at ≤-20 °C.
  • Substrate - S6K synthetic peptide substrate (CKRRRLASLR) diluted in distilled or deionized water to a final concentration of 1.0 mg/mL.
  1. Thaw the [33P]-ATP Assay Cocktail in a shielded container in a designated radioactive work area.
  2. Thaw the Active p70S6K, Kinase Assay Buffer I, Substrate, and Kinase Dilution Buffer on ice.
  3. In a pre-cooled microfuge tube, add the following reaction components bringing the initial reaction volume up to 20 μL.
    a. Diluted Active p70S6K: 10 μL
    b. Substrate (1 mg/mL Stock Solution): 5 μL
    c. Distilled or deionized water (2-8 °C): 5 μL
  4. Set up the blank control as outlined in step 3, excluding the addition of the substrate. Replace the substrate with an equal volume of distilled or deionized water.
  5. Initiate the reaction by the addition of 5 μL [33P]-ATP Assay Cocktail, bringing the final volume up to 25 μL. Incubate the mixture in a water bath at 30 °C for 15 minutes.
  6. After the 15 minute incubation period, terminate the reaction by spotting 20 μL of the reaction mixture onto individual pre-cut strips of phosphocellulose P81 paper.
  7. Air dry the pre-cut P81 strip and sequentially wash in a 1% phosphoric acid solution (add 10 mL of phosphoric acid to 990 mL of distilled or deionized water) with constant gentle stirring. It is recommended that the strips be washed a total of three times for approximately 10 minutes each.
  8. Count the radioactivity on the P81 paper in the presence of scintillation fluid in a scintillation counter.
  9. Determine the corrected cpm by subtracting the blank control value (see step 4) for each sample and calculate the kinase specific activity as outlined below.


    Calculation of [33P]-ATP Specific Activity (SA) (cpm/pmol)
    Specific Activity (SA) = cpm for 5 μL [33P]-ATP/pmol of ATP (in 5 μL of a 250 μM ATP stock solution, i.e. 1250 pmol)

    Calculation of Kinase Specific Activity (SA) (pmol/minutes/μg or nmol/minutes/mg)
    Corrected cpm from reaction / [(SA of 33P-ATP in cpm/pmol) x (Reaction time in minutes) x (Enzyme amount in μg or mg)] x [(Reaction volume) / (Spot Volume)]

Scientific Data

SDS-PAGE Recombinant Human Active p70 S6 Kinase Protein SDS-PAGE View Larger

The approximate molecular weight is 76 kDa and the average purity is 85%.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: p70 S6 Kinase

p70S6K is responsible for the phosphorylation of 40S ribosomal protein S6 and is ubiquitously expressed in human adult tissues. p70S6K is activated by serum stimulation and this activation is inhibited by wortmannin and rapamycin. p70S6K activity undergoes changes in the cell cycle and increases 20-fold in G1 cells released from G0 (2). p70S6K activation requires sequential phosphorylations at proline-directed residues in the putative autoinhibitory pseudosubstrate domain, as well as at T389, a site phosphorylated by phosphoinositide-dependent kinase 1 (PDK-1) (1, 2).

References
  1. Ferrari, S. et al. (1994) Crit. Rev. Biochem. Mol. Biol. 29:385.
  2. Edelmann, H.M. et al. (1996) J. Biol. Chem. 271:963.
Entrez Gene IDs
6198 (Human); 72508 (Mouse); 83840 (Rat)
Alternate Names
EC 2.7.11; EC 2.7.11.1; p70 ribosomal S6 kinase alpha; p70 S6 kinase alpha; p70 S6 Kinase; p70 S6 kinase, alpha 1,70 kDa ribosomal protein S6 kinase 1; p70 S6 kinase, alpha 2; p70 S6KA; p70 S6K-alpha; p70(S6K)-alpha; p70-alpha; p70-S6K; P70S6K1; PS6K; ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase I; ribosomal protein S6 kinase, 70kD, polypeptide 1; ribosomal protein S6 kinase, 70kDa, polypeptide 1; RPS6KB1; S6K; S6K1; S6K1p70-S6K 1; S6K-beta-1; serine/threonine kinase 14 alpha; Serine/threonine-protein kinase 14A; STK14A

Citations for Recombinant Human Active p70 S6 Kinase Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

4 Citations: Showing 1 - 4
Filter your results:

Filter by:

  1. Deregulated PP1? phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism
    Authors: M Chen, L Wan, J Zhang, J Zhang, L Mendez, JG Clohessy, K Berry, J Victor, Q Yin, Y Zhu, W Wei, PP Pandolfi
    Nat Commun, 2018-01-15;9(1):159.
    Applications: Bioassay
  2. Effective combinatorial immunotherapy for castration-resistant prostate cancer
    Authors: X Lu, JW Horner, E Paul, X Shang, P Troncoso, P Deng, S Jiang, Q Chang, DJ Spring, P Sharma, JA Zebala, DY Maeda, YA Wang, RA DePinho
    Nature, 2017-03-20;543(7647):728-732.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells.
    Authors: Lee H, Mustafa A, Hudes G, Kruger W
    PLoS ONE, 2015-07-02;10(7):e0131464.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  4. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
    Authors: Ip CK, Cheung AN, Ngan HY
    Oncogene, 2011-01-24;30(21):2420-32.
    Species: Human
    Sample Types: Protein
    Applications: Binding Assay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Active p70 S6 Kinase Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Active p70 S6 Kinase Protein, CF and earn rewards!

Have you used Recombinant Human Active p70 S6 Kinase Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review